Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain)

Vaccine

Volumn 29, Issue 16, 2011, Pages 2840-2845

  Jiménez García, Rodrigo ^a   Rodríguez Rieiro, Cristina ^a   Hernández Barrera, Valentín ^a   Andres, Ana Lopez de ^a   Cuadrado, Agustin Rivero ^a   Laso, Angel Rodriguez ^b   Carrasco Garrido, Pilar ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b Consejería de Sanidad de Madrid Julián Camarillo ^*  (Spain)

Author keywords

Adherence; Coverage; Influenza; Strategies; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPAIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SPAIN; VACCINATION; YOUNG ADULT;

EID: 79953230934     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.004     Document Type: Article

References (38)

1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-186.
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292(11):1333-1340.
3. Molinari N.A., Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25(27):5086-5096.
4. Centers for Disease Control Prevention Prevention and control of influenza with vaccines. recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR 2010, 59(RR-8):1-62.
5. Schanzer D.L., Langley J.M., Tam T.W. Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada. Vaccine 2008, 26(36):4697-4703.
6. Lenglet A.D., Hernando V., Rodrigo P., Larrauri A., Donado J.D., de Mateo S. Impact of flu on hospital admissions during 4 flu seasons in Spain, 2000-2004. BMC Public Health 2007, 7:197.
7. Hak E., Buskens E., van Essen G.A., de Bakker D.H., Grobbee D.E., Tacken M.A., et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005, 165(3):274-280.
8. Ciszewski A., Bilinska Z.T., Brydak L.B., Kepka C., Kruk M., Romanowska M., et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008, 29(11):1350-1358.
9. Looijmans-Van den Akker I., Verheij T.J., Buskens E., Nichol K.L., Rutten G.E., Hak E. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care 2006, 29(8):1771-1776.
10. Ministerio de Sanidad (Ministry for Health). Vacunaciones en adultos. Available at: [accessed 4 October 2010]. http://www.msc.es/ciudadanos/proteccionSalud/vacunaciones/docs/recoVacunasAdultos.pdf.
11. Servicio de Prevención de la Enfermedad. Dirección General de Salud Pública y Alimentación. Consejería de Sanidad y Consumo de la Comunidad de Madrid. Campaña de vacunación antigripal y antineumocócica 2005. Available at: [accessed 4 October 2010]. http://www.madrid.org/cs/Satellite.
12. Centers for Disease Control Prevention Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices. MMWR 2000, 49(RR-3):6.
13. Honkanen P.O., Keistinen T., Kivela SL The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 1997, 15(3):317-320.
14. Vázquez-Fernández del Pozo S., Hernández-Barrera V., Carrasco-Garrido P., Gil de Miguel A., Jiménez-García R. Changes in influenza vaccination coverage in Spain from 2001 to 2003, Analysis by autonomous communities. Gac Sanit 2007, 21(1):10-17.
15. Mayo Montero E., Hernández Barrera V., Carrasco Garrido P., Gil de Miguel A., Jiménez García R. Evolución en las coberturas vacunales antigripales en la Comunidad de Madrid entre los años 1993 y 2001. Vacunas 2005, 6(2):41-45.
16. Comunidad Autonoma de Madrid. Consejería de Sanidad. Encuesta de salud 2007. Madrid Regional Health Survey 2007. Available at: [accessed 4 October 2010]. http://www.madrid.org/cs/Satellite?cid=1142341580032%26language=es%26pageid=1156329914003%26pagename=PortalSalud%2FPTSA_Generico_FA%2FPTSA_pintarGenerico%26vest=1156329914003.
17. Comunidad Autonoma de Madrid. Instituto de estadistica. Population and Households. Structure and evolution. Available at: [accessed 4 October 2010]. http://www.madrid.org/iestadis/fijas/estructu/general/anuario/descarga/anu2-1-1.xls.
18. Ministerio de Sanidad y Consumo. Encuesta Nacional de Salud 2006. (Spanish National Health Survey 2006). Available from [accessed 4 October 2010]. http://www.msc.es/estadEstudios/estadisticas/encuestaNacional/encuestaNac2006/metodENS2006.pdf.
19. Instituto Nacional de Estadística. Encuesta Nacional de Salud de España 2006 (Spanish National Health Survey 2006). Details on the evaluation of non respondents. Available from [accessed 4 October 2010]. http://www.msc.es/estadEstudios/estadisticas/encuestaNacional/encuestaNac2006/evaluacionFaltaResp.pdf.
20. Monto A.S. Seasonal influenza and vaccination coverage. Vaccine 2010, 28(Suppl. 4):D33-44.
21. Jiménez-García R., Hernández-Barrera V., Carrasco-Garrido P., López de Andrés A., Pérez N., de Miguel A.G. Influenza vaccination coverages among children, adults, health care workers and immigrants in Spain: related factors and trends, 2003-2006. J Infect 2008, 57(6):472-480.
22. Rodríguez-Rieiro C., Domínguez-Berjón M.F., Esteban-Vasallo M.D., Sánchez-Perruca L., Astray-Mochales J., Fornies D.I., et al. Vaccination coverage against 2009 seasonal influenza in chronically ill children and adults: analysis of population registries in primary care in Madrid (Spain). Vaccine 2010, 28(38):6203-6209.
23. Lu P., Bridges C.B., Euler G.L., Singleton J.A. Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine 2008, 26(14):1786-1793.
24. Center for Disease Control. Self-reported influenza vaccination coverage trends 1989-2008. Available at [accessed 11 October 2010]. http://www.cdc.gov/flu/professionals/vaccination/pdf/NHIS89_08fluvaxtrendtab.pdf.
25. Kwong J.C. Flu shots in Canada: are they getting to those who need them most?. Healthc Q 2008, 11(2):20-22.
26. Kwong J.C., Maaten S., Upshur R.E., Patrick D.M., Marra F. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis 2009, 49(5):750-756.
27. Kwong J.C., Stukel T.A., Lim J., McGeer A.J., Upshur R.E., Johansen H., et al. The effect of universal influenza immunization on mortality and health care use. PLoS Med 2008, 5:e211.
28. Honkanen P., Läärä E., Pyhälä R., Kivelä S.L., Helena Mäkelä P. Comparison of two vaccination programmes in preventing influenza-related hospitalization among the elderly during two consecutive seasons. Scand J Infect Dis 2006, 38(6-7):506-511.
29. Kroneman M., van Essen G.A., John Paget W. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine 2006, 24(5):622-628.
30. Vila-Córcoles A., Ochoa-Gondar O., Ester F., Sarrá N., Ansa X., Saún N., et al. Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up. BMC Public Health 2006, 6:231.
31. Kee S.Y., Lee J.S., Cheong H.J., Chun B.C., Song J.Y., Choi W.S., et al. Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect 2007, 55(3):273-281.
32. Bridges C.B., Thompson W.W., Meltzer M.I., Reeve G.R., Talamonti W.J., Cox N.J., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000, 284(13):1655-1663.
33. Sen FYC. Programa de Actividades Preventivas y de Promoción de la Salud (PAPPS) Available at [accessed 13 October 2010]. http://www.papps.org/suplemento_ap_09.php.
34. Aballéa S., De Juanes J.R., Barbieri M., Martin M., Chancellor J., Oyagüez I., et al. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain. Vaccine 2007, 25(39-40):6900-6910.
35. Willis B.C., Ndiaye S.M., Hopkins D.P., Shefer A. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 2005, 54(RR-5):1-11. Task Force on Community Preventive Services.
36. Mac Donald R., Baken L., Nelson A., Nichol K.L. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999, 16(3):173-177.
37. Zimmerman R.K., Raymund M., Janosky J.E., Nowalk M.P., Fine M.J. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 2003, 21(13-14):1486-1491.
38. Michel J.P., Chidiac C., Grubeck-Loebenstein B., Johnson R.W., Lambert P.H., Maggi S., et al. Coalition of advocates to vaccinate of Western European citizens aged 60 years and older. Aging Clin Exp Res 2009, 21(3):254-257.